Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds William Blair Upgrades FibroGen to Outperform

William Blair Upgrades FibroGen to Outperform

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

byBenzinga Newsdesk

January 31, 2023

1 minute read

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

Pinterest, Cloudflare And 2 Other Stocks Insiders Are Selling

By Lisa Levin

September 29, 8:02 AM

The Nasdaq 100 closed higher by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

IMKTA

Raymond James Maintains Strong Buy on Marathon Petroleum, Raises Price Target to $165

By Benzinga Newsdesk

February 1, 5:57 AM

Raymond James analyst Justin Jenkins maintains Marathon Petroleum (NYSE:MPC) with a Strong Buy and raises the price target from $155 to $165.

MPC

Raymond James Upgrades Frontier Communications to Strong Buy, Raises Price Target to $37

By Benzinga Newsdesk

February 27, 8:14 AM

Raymond James analyst Frank Louthan upgrades Frontier Communications (NASDAQ:FYBR) from Outperform to Strong Buy and raises the price target from $36 to $37.

FYBR

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday

By Avi Kapoor

January 9, 11:59 AM

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

ACCD

William Blair Upgrades FibroGen to Outperform

Related Posts

Pinterest, Cloudflare And 2 Other Stocks Insiders Are Selling

Raymond James Maintains Strong Buy on Marathon Petroleum, Raises Price Target to $165

Raymond James Upgrades Frontier Communications to Strong Buy, Raises Price Target to $37

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday